03/05/2024  16:01:52 Var. +0.39 Volume Denaro03/05/2024 Lettera03/05/2024 Capitalizzazione di mercato Dividend Y. Rapporto P/E
57.14EUR +0.69% 196
Fatturato: 11,199.44
-Quantità in denaro: - -Quantità in lettera: - 10.93 bill.EUR 0.88% 19.15

Descrizione business

Eurofins Scientific is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. Eurofins believes it is a worldwide leader in its field. The Group offers a portfolio of more than 150,000 validated analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products. Through research and development and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Dr. Gilles G. Martin
Consiglio di amministrazione
Gabriel Julia, Dr. Timothy S. Oostdyk, Joachim Reichelt, Yvoine Rémy, François Vigneau, Brian Williams, Laurent Lebras, Dr. Christian Wurst, Sean Murray, Ramón Armas, Beth DiPaolo, Natalia Shuman, Gregg Tiemann
Consiglio di sorveglianza
Dr. Gilles Martin, Dr. Yves-Loïc Martin, Evie Roos, Fereshteh Pouchantchi, Ivo Rauh, Pascal Rakovsky, Patrizia Luchetta, Valérie Hanote
 

Dati aziendali

Name: Eurofins Scientific S.A.
Indirizzo: Chausée de Malines 455,B-1950 Kraainem
Telefono: +32-2-766-1620
Fax: +32-2-766-1639
E-mail: info@eurofins.com
Internet: www.eurofins.com
Industria: Biotechnology
Settore: Biotechnology
Sub settore: Biotechnology
Fine dell'anno finanziario: 31/12
Flottante libero: 66.60%
Data dell'IPO: 24/10/1997

Rapporti con gli investitori

Name: -
IR telefono: +32-2-769-7383
IR Fax: -
IR e-mail: ir@eurofins.com

Company calendar

CW 30 | 24/07/2024 Interim Report 2nd Quarter/6 Months
CW 43 | 22/10/2024 Interim Report 3rd Quarter/9 Months
 

Principali azionisti

Free Floa
 
66.80%
Martin Family
 
32.70%
Treasury shares
 
0.50%